Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)—study protocol for a randomised controlled trial

INTRODUCTION: Multiple sclerosis is a chronic inflammatory, degenerative disease of the central nervous system manifesting at first with relapses in about 85% of cases. In Germany, intravenous therapy with high-dose corticosteroids is the treatment standard of acute relapses. The treatment leads to...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahn, Anne Christin, Wenzel, Lisa, Icks, Andrea, Stahmann, Alexander, Scheiderbauer, Jutta, Grentzenberg, Kristina, Vomhof, Markus, Montalbo, Joseph, Friede, Tim, Heesen, Christoph, Köpke, Sascha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882468/
https://www.ncbi.nlm.nih.gov/pubmed/33583424
http://dx.doi.org/10.1186/s13063-021-05059-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882468/
https://www.ncbi.nlm.nih.gov/pubmed/33583424
http://dx.doi.org/10.1186/s13063-021-05059-1

Ejemplares similares